Auckland UniServices, Ltd
UniServices is a not-for-profit, University of Auckland–owned organisation that translates university research into commercial and public-good outcomes. It manages investment funds and investment committees, licenses intellectual property, supports spin-outs and start-ups, and delivers research-informed services and professional learning programmes across sectors including health, education, public policy, materials and digital technologies. UniServices also hosts and supports large-scale research and monitoring initiatives and international collaborations.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
US-12508268-B2
View DetailsRapid mercury-free photochemical microencapsulation/nanoencapsulation at ambient conditions
US-12233434-B2
View DetailsInhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
US-11826316-B2
View Details
Inhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
US-12508268-B2
View DetailsRapid mercury-free photochemical microencapsulation/nanoencapsulation at ambient conditions
US-12233434-B2
View DetailsInhibitors of tryptophan dioxygenases (IDO1 and TDO) and their use in therapy
US-11826316-B2
View DetailsServices
Managing the University of Auckland Inventors’ Fund, convening investment committees and co-investing with partners to support research-backed startups.
IP protection advice, commercialisation workshops, mentorship and connections to incubators and accelerators to enable spin‑out formation and growth.
Design and delivery of public‑good programmes and professional services (examples include immunisation training, family violence clearinghouse, education PLD and marine conservation co-location projects).
Coordinating multi-site international vaccine safety monitoring, data harmonisation and large-cohort analytics to detect rare adverse events and support public health decision-making.
Co-designed educator and workforce PLD programmes adapted to local and cultural contexts (examples include Tapasā PLD for Pacific learners and other bespoke school PLD).
Providing partnership and co-location arrangements to enable collaboration between research organisations and international NGOs or industry partners.
Managing the University of Auckland Inventors’ Fund, convening investment committees and co-investing with partners to support research-backed startups.
IP protection advice, commercialisation workshops, mentorship and connections to incubators and accelerators to enable spin‑out formation and growth.
Design and delivery of public‑good programmes and professional services (examples include immunisation training, family violence clearinghouse, education PLD and marine conservation co-location projects).
Coordinating multi-site international vaccine safety monitoring, data harmonisation and large-cohort analytics to detect rare adverse events and support public health decision-making.
Co-designed educator and workforce PLD programmes adapted to local and cultural contexts (examples include Tapasā PLD for Pacific learners and other bespoke school PLD).
Providing partnership and co-location arrangements to enable collaboration between research organisations and international NGOs or industry partners.
Expertise Areas
- Research commercialisation and venture creation
- Technology licensing and intellectual property management
- Investment management and fund administration
- Digital health and medtech
Key Technologies
- Digital twins and process simulation
- AI-driven 3D biomechanical modelling
- Microfluidics
- Photonics for sensing and sorting
News & Updates
Summary metrics and highlights including numbers of spin-outs, licensed patents, fund valuation and volumes of training and clinical queries handled by managed services.
Reported investment in over 75 companies and licensing of more than 540 patent families (institutional performance to date).
36 new companies launched between 2020–2025 and 35 patents licensed in 2024; reported Inventors’ Fund fair value reported at NZ$41m (end of 2023).
Summary metrics and highlights including numbers of spin-outs, licensed patents, fund valuation and volumes of training and clinical queries handled by managed services.
Reported investment in over 75 companies and licensing of more than 540 patent families (institutional performance to date).
36 new companies launched between 2020–2025 and 35 patents licensed in 2024; reported Inventors’ Fund fair value reported at NZ$41m (end of 2023).